KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Raw Materials: 2021-2024

Historic Raw Materials for Rigel Pharmaceuticals (RIGL) over the last 4 years, with Dec 2024 value amounting to $1.1 million.

  • Rigel Pharmaceuticals' Raw Materials rose 342.96% to $7.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.0 million, marking a year-over-year increase of 342.96%. This contributed to the annual value of $1.1 million for FY2024, which is 76.63% down from last year.
  • According to the latest figures from FY2024, Rigel Pharmaceuticals' Raw Materials is $1.1 million, which was down 76.63% from $4.6 million recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Raw Materials registered a high of $5.1 million during FY2021, and its lowest value of $1.1 million during FY2024.
  • Moreover, its 3-year median value for Raw Materials was $4.6 million (2022), whereas its average is $3.4 million.
  • As far as peak fluctuations go, Rigel Pharmaceuticals' Raw Materials rose by 1.19% in 2023, and later crashed by 76.63% in 2024.
  • Yearly analysis of 4 years shows Rigel Pharmaceuticals' Raw Materials stood at $5.1 million in 2021, then declined by 11.42% to $4.6 million in 2022, then climbed by 1.19% to $4.6 million in 2023, then slumped by 76.63% to $1.1 million in 2024.